0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç×È£¸£¸ó¿ä¹ýÀ» ¹Þ´Â À¯¹æ¾Ï ¿©¼ºÀÇ °»³â±â Áõ»ó°ú ¿¬°ü º¯Àΰ£ÀÇ ºÐ¼®

Menopausal Symptoms and Associated Factors in Breast Cancer Patients Receiving Hormone Therapy

ÀÓ»ó°£È£¿¬±¸ 2017³â 23±Ç 1È£ p.120 ~ 129
KMID : 1004620170230010120
±è¿µ¶õ ( Kim Young-Lan ) - ´Ü±¹´ëÇб³ °£È£´ëÇÐ

¹Î¿­ÇÏ ( Min Yul-Ha ) - °¡Ãµ´ëÇб³ °£È£´ëÇÐ

Abstract

Purpose: The purpose of this study was to identify the degree of menopause symptoms and associated factors in patients with breast cancer who were receiving hormone therapy.

Methods: Data were collected with questionnaires from 150 patients with breast cancer who had been on hormone therapy at a hospital in Seoul. Data were analyzed with the t-test, ANOVA, and Pearson correlation coefficient to compare the degree of menopause symptoms by demographic, clinical and psychological factors.

Results: The mean menopause symptoms score was 13.39¡¾7.97. Most participants reported having hot flushes and sweating (75.3%), physical and mental exhaustion (82.7%) and sexual problems (64.7%). Menopause symptoms and depression were correlated with each other (p<.01). Somato-vegetative symptoms were different significantly by age, menopausal status at time of operation, occupation and tumor. Psychological symptoms were different significantly by marital status, operation type and chemotherapy. Urogenital symptoms were different significantly by prior history of cancer, occupation, operation type and radiation therapy.

Conclusion: These findings can be used to provide tailored nursing interventions by identifying high risk groups for menopausal symptom among breast cancer patients receiving hormone therapy.
KeyWords

Breast Neoplasms, Hormonal Antineoplastic Agents, Menopause, Medication Adherence, Depression
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI)